BCPC BALCHEM CORP

BCPC financial statements, revenue, balance sheet, cash flow, and SEC filings

CIK: 9326 Exchange: Nasdaq SIC: 2800 (Chemicals & Allied Products) Latest filing: 10-Q filed Oct 23, 2026 Data checked: Oct 26, 2026
Showing 3 of 17 annual and 0 of 65 quarterly periods. Full history available with a free account or via API.

▼ Company Profile

Filer Category
Large accelerated filer
Entity Type
Operating
Public Float
$5.14B (Jun 2025)
Industry (SIC)
2800 Chemicals & Allied Products
Incorporated
MD
Fiscal Year End
December (1231)
Phone
(845) 326-5600
EIN
132578432
Headquarters
MONTVALE, NJ, 07645
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.

▼ Key Metrics (TTM)

As of Sep 30, 2026
Financials
Revenue
$1.11B
Net Income
$170.85M
Total Assets
$1.70B
Total Equity
$1.33B
Total Debt
-
Free Cash Flow
-
Ratios
Gross Margin
36.5%
Operating Margin
20.7%
Net Margin
15.4%
Return on Equity
12.9%
Return on Assets
10%
Current Ratio
2.47x

▼ FY 2025 Summary Analysis

Annual report ending Dec 31, 2025

Overview and Growth

Fiscal 2025 results for BALCHEM CORP combined $1.04B of revenue with net income of $154.84M and an operating cash inflow of $216.56M. Revenue of $1.04B sets the scale for evaluating how effectively sales translated into profit and cash during the year. The top line expanded 8.8% from $953.68M in fiscal 2024, increasing the company’s operating scale. The company reported diluted EPS of $4.75, adding a shareholder-level measure to the absolute income figures considered below. Against diluted EPS of $3.93 in fiscal 2024, the current result was 20.9% higher. The diluted weighted-average share count was 32.60M, linking total earnings with the per-share result received by shareholders. At period end, total assets were $1.69B, framing the scale of the company’s operating and financing commitments. The revenue-to-assets relationship was 0.62x, showing the sales generated relative to the resources carried on the balance sheet.

Profitability

The first profit layer was $370.63M of gross profit, the amount available after reported direct revenue costs to absorb operating expenses. Gross margin was 35.7%, so that share of each revenue unit remained after the cost of revenue reported for the period. Operations produced $209.33M of income after the reported operating expense base, before the remaining non-operating and tax effects. The operating result equaled 20.2% of revenue, placing the absolute operating-income figure in the context of the company’s sales base. Net income came to $154.84M, completing the progression from revenue through gross and operating profitability to the final reported result. The final earnings result represented 14.9% of revenue, connecting the absolute net income figure with the company’s top-line scale. EBITDA was $255.02M, adding a pre-interest, tax, depreciation, and amortization view of the company’s earnings capacity. The reported income-tax provision was $44.19M, the amount recognized between pretax income and the final net-income result. The relationship between net income and period-end equity was 12.3%, indicating the profitability achieved on book capital. The net-income-to-assets relationship measured 9.2%, showing earnings relative to the full balance sheet. Against $128.47M in fiscal 2024, the current $154.84M bottom line finished above the prior-year result in absolute terms.

Liquidity and Capital Structure

Total assets were $1.69B, supported by $428.84M of liabilities and $1.26B of shareholder equity. At period end, current assets of $365.61M compared with current liabilities of $176.38M, defining the company’s short-term resource position. The current ratio was 2.07x, with current assets exceeding current liabilities and providing a short-term liquidity cushion. Cash and equivalents totaled $74.57M, identifying the most liquid reported component available within the broader current-asset balance. Cash and equivalents represented 42.3% of current liabilities, showing the portion of near-term obligations matched by reported cash alone. Equity equaled 74.6% of assets, showing the shareholder-capital layer within the company’s balance sheet. Liabilities represented 25.4% of total assets, quantifying the liability-funded share of the company’s resource base. Measured against total assets, cash and equivalents represented 4.4%, a balance-sheet composition measure rather than a liquidity forecast. Total assets were 7.0% higher than fiscal 2024 assets of $1.58B, measuring the company’s own balance-sheet change. Against $1.15B of equity in fiscal 2024, the current book-equity balance moved 9.3% and ended higher. Compared with $49.52M in fiscal 2024, the current cash balance moved 50.6% and finished higher.

Cash Flow and Earnings Quality

Cash flow from operations was $216.56M, a reported cash inflow that can be compared directly with net income and capital spending. Operating cash flow equaled 1.4x of net income, showing how strongly accounting earnings converted into cash from operations. The operating cash outcome moved from $182.00M in fiscal 2024 to $216.56M, ending above the prior-year level.
Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated .
Sources and calculation details

Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.

Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.

Annual financial statements for BALCHEM CORP
Metric FY2025 📄 FY2024 📄 FY2023 📄
Income Statement
REVENUE
Revenue $1.04B $953.68M $922.44M
Cost of Revenue $666.53M $617.48M $620.38M
Gross Profit $370.63M $336.21M $302.06M
OPERATING EXPENSES
R&D Expense $18.51M $16.79M $15.05M
SG&A Expense $67.42M $67.59M $53.42M
Other Operating Expenses (derived) $75.37M $68.92M $74.40M
Operating Income $209.33M $182.91M $159.19M
NON-OPERATING INCOME / EXPENSE
Other Income/Expense $-77.00K $72.00K $681.00K
Income Tax $44.19M $37.98M $28.72M
Net Income $154.85M $128.48M $108.54M
PER SHARE & SUPPLEMENTAL
Diluted EPS $4.75 $3.93 $3.35
Diluted Shares 32.60M 32.72M 32.45M
EBITDA $255.02M $230.88M $214.13M
Depreciation & Amortization $45.69M $47.97M $54.94M
Balance Sheet
ASSETS
Cash & Equivalents $74.57M $49.52M $64.45M
Accounts Receivable $143.60M $119.66M $125.28M
Inventory $131.45M $130.80M $109.52M
Other Current Assets $6.22M $5.74M $7.19M
Current Assets $365.61M $313.77M $314.24M
PP&E (Net) $306.65M $282.15M $276.04M
Goodwill $816.38M $780.03M $778.91M
Intangible Assets $132.99M $132.48M $191.21M
Other Noncurrent Assets $18.13M $17.32M $16.95M
Noncurrent Assets $1.32B $1.26B $1.28B
Total Assets $1.69B $1.58B $1.60B
LIABILITIES
Current Liabilities $176.38M $157.69M $148.49M
Noncurrent Liabilities $252.46M $267.77M $394.74M
Total Liabilities $428.84M $425.46M $543.23M
EQUITY
Common Stock $2.14M $2.17M $2.15M
Additional Paid-in Capital $92.33M $174.00M $145.65M
Retained Earnings $1.12B $997.49M $897.49M
Accumulated OCI $41.55M $-23.75M $8.69M
Total Equity $1.26B $1.15B $1.05B
Total Liabilities & Equity $1.69B $1.58B $1.60B
SUPPLEMENTAL
Shares Outstanding 32.06M 32.53M 32.25M
Check: A − (L + E + Temp. Equity) - - -
Cash Flow Statement
Cash from Operations $216.56M $182.00M $183.76M
Capital Expenditures - - -
Cash from Investing $-43.89M $-59.74M $-34.81M
Cash from Financing $-152.81M $-133.82M $-153.32M
Free Cash Flow - - -
Beginning Cash (CFS) $49.52M $64.45M $66.56M
Net Change in Cash $19.86M $-11.55M $-4.37M
Effect of FX on Cash $5.20M $-3.38M $2.26M
Calculated Ending Cash $74.57M $49.52M $64.45M
Cash per BS $74.57M $49.52M $64.45M
Cash scope difference (CFS − BS) - - -
Cash per CFS $74.57M $49.52M $64.45M

Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.

Create Free Account Log In
🔒

Quarterly data and charts require a free account

Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.

▼ Frequently Asked Questions

What is BALCHEM CORP's annual revenue?

BALCHEM CORP reported $1.11B in revenue for trailing twelve months (ending September 2026). Revenue figures are sourced from the company's annual SEC EDGAR filing.

Is BALCHEM CORP profitable?

Yes. BALCHEM CORP reported $170.85M in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.